Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

Cited by (326)

Items 301–326 of 326

1. Kynureninase in tumor immunotherapy: From mechanisms to applications
   ZengGuang Liu, Jiaxin Yin, Yu Tao, Shengcai Yang, Ziling Liu, Quanshun Li · 2026 · Precision medicine and engineering.
2. Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects
   Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi, Priya Priyadarshini Nayak, Ashish Singh Chauhan, Siya Singla, Djamila Polatova, Fadhil Faez Sead, Reza Akhavan‐Sigari · 2026 · Cancer Treatment and Research Communications
3. Mécanismes de résistance aux thérapies ciblées du mélanome : implication du facteur de transcription Aryl hydrocarbon Receptor
   Nina Tardif · 2019 · theses.fr (ABES)
4. Impact de la perte du transporteur mitochondrial UCP2 sur la physiologie de l'intestin et l'immunité favorisant la tumorigenèse colorectale
   Angèle Luby · 2024 · theses.fr (ABES)
5. Integrative QSP Modeling of Cancer Stem Cells in Triple‐Negative Breast Cancer: Impacts on Tumor Immunity and Response to Immune Checkpoint Inhibitors
   Junsheng Xue, Weizhe Jian, Tianyu Wang, Zhi-Gang Jiang, Xinyu Hou, Qirui Yang, Tianyu Bao, Lei Cai, Enze Gan, Chen Liu et al. · 2026 · CPT Pharmacometrics & Systems Pharmacology
6. Targeting the amino acid metabolic axis: the Achilles’ heel of tumor cells
   Zheyu Hu, Yiwei Wang, Qian Ma · 2026 · Amino Acids
7. Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models
   Kunyuan He, Shaofeng Yang, Ke Zhang, Ling Yang, Fei Song · 2026 · Frontiers in Immunology
8. N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications
   Ming-Zhu Jin, Wen Di · 2026 · Frontiers in Immunology
9. Esophageal epithelial cell-derived kynurenine drives Th17 inflammation in reflux esophagitis and is targeted by Xuanfu Daizhe decoction
   Jing Xun, Qi Gao, Huichao Yang, Jinlu Zhang, Yu Wang, B Liu, Xiaolin Jiang, Dihua Li, Lin Lang, Haiwei Mei et al. · 2026 · Chinese Medicine
10. Microbial influence on tryptophan metabolism in tumors:Mechanisms and potential clinical applications
    Rui Yang, Kaikai He, Yan Yang, Lisong Teng · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
11. Metabolic Bottlenecks and Opportunities: Reshaping the Tumor Microenvironment for Cancer Immunotherapy
    Jianing Zhang, Zimei Tang, Yiran Wang, Jiaying Wan, Yajing Zhou, Jiexiao Li, Jie Ming · 2026 · Cells
12. Rationally engineered hydrogel-enabled modulation of tumor metabolism for enhanced antitumor immunotherapy
    Xiaohong Li, Kang Yang, Xiaoyuan Liang, Fuyu Qi, Yonggang Lv · 2026 · Precision medicine and engineering.
13. Tryptophan metabolism in colorectal cancer: From mechanistic insights to novel therapeutic strategies
    Ran Wang, Wenke Shen, Ping Yang, Dongxue Yang, Yuepeng Cao, Yuping Zhou · 2026 · Clinical and Translational Medicine
14. Cobalt-mediated suppression of IFN-γ–JAK–STAT1 signaling reprograms IDO1-driven immunosuppression for metalloimmunotherapy
    Tianyi Jiang, Xiaowan Huang, Zhixin Wu, Gulinaizaier Abudusaimaiti, Yang Song, Hongtao Duan, Yuping Zhou, Yaoxu Chen, Sitong Du, Hao Zhang et al. · 2026 · Science Advances
15. Tumor CD147-mediated enhanced tryptophan metabolism boosts NSCLC immunosuppression via inducing CD8+ T cell exhaustion
    Han-Ge Liu, Zhao Liang, Ming-Yan Shi, Yan-Lu Xiong, Xian-Ting Wei, Kai-Li Xue, Ye Tian, Xiaohong Chen, Huijie Bian, Zhi‐Nan Chen et al. · 2026 · Genes & Diseases
16. Metabolic engineering of Salmonella enterica for coupled kynurenine sensing and depletion enhances antitumor efficacy
    Kontham Kulangara Varsha, Akeem Santos, Tingting Xiao, Zeneng Wang, Rashmi Bharti, Mahima Arora, Austin M Williams, John Peterson, Justin D. Lathia, Stanley L. Hazen et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
17. Serum kynurenine-to-tryptophan ratio and long-term outcomes after PD-1/PD-L1 blockade: Results from a prospective cohort study in advanced non-small cell lung cancer
    Anna Siemiątkowska, Barbara Kuźnar-Kamińska, Maciej Bryl, Katarzyna Kosicka, Hanna Winiarska, Iwona Gołda-Gocka, Franciszek Krzysztof Główka · 2026 · Therapeutic Advances in Medical Oncology
18. From metabolic starvation to precision therapy: engineering amino acid-targeted tumor therapeutics
    Mingyue Wang, Haitao Ding, Lei Xu, Yunkun Li · 2026 · International Journal of Pharmaceutics
19. Tryptophan metabolism in heart failure: Mechanisms, biomarker potential, and therapeutic implications
    Pingge HE, Hongbo Chang, Hong Wu, Qiujia Kang, Shaoang WANG, Lei Xu, Zhentao Wang · 2026 · European Journal of Pharmacology
20. Advanced Nanomedicines for Cancer Metabolic Therapy
    Qiu‐Yi Duan, Chun Tian, Xi Cheng, Liying Wang, Minfeng Huo, Jianlin Shi · 2026 · Advanced Materials
21. Magnetic Thermal Ablation Combined with Temporally Coordinated CpG Immunotherapy Promotes cDC1‐Dependent Immune Priming in Hepatocellular Carcinoma
    Jiakun Yang, Nailin Yang, Shuangshuang Ji, Siping Meng, Di Wang, 梁文军, Xuming Bai, Yong Hyun Jin, Xingwei Sun · 2026 · Advanced Science
22. X-ray-Triggered Nanoadjuvant Enabling Spatiotemporal Immunometabolic Modulation for Pyroptosis-Enhanced Radiotherapy
    Wenjun Liu, Yushi Chen, Yanmin Xiao, Jin Gao, Shanwen Hu, Lanlan Chen, Jibin Song, Huanghao Yang · 2026 · Nano Letters
23. BindingDB Entry 50015562: Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.
    BindingDB · 2023 · UC San Diego
24. BindingDB Entry 50017752: Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase.
    BindingDB · 2023 · UC San Diego
25. BindingDB Entry 50007461: Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation.
    BindingDB · 2021 · UC San Diego
26. Engineered nanobiotechnology for cancer immunotherapy
    Chengqiong Mao, Yang Liu, Jun Wang · 2026 · 中国科学通报：英文版